This feature serves as a complementary immune surveillance mechanism to T cells, allowing the detection of cancer cells or viral-infected cells that downregulate or inhibit the expression of MHC-I molecules to evade MHC-TCR-based T cell detection [200]. The gene discussed is HLA-C; the disease is cancer.